Clinical Outcomes after Early and Delayed Radioiodine Remnant Ablation in Patients with Low-Risk Papillary Thyroid Carcinoma: Propensity Score Matching Analysis

Clinical Outcomes after Early and Delayed Radioiodine Remnant Ablation in Patients with Low-Risk Papillary Thyroid Carcinoma: Propensity Score Matching Analysis

The clinical outcomes of delayed radioiodine remnant ablation (RRA) therapy in patients with low-risk papillary thyroid carcinoma (PTC) are unclear. We aimed to evaluate the clinical impact of the interval between total thyroidectomy (TT) and RRA therapy in patients with low-risk PTC. We included 52...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Endocrinology and metabolism (Seoul) 2020, 35(4), , pp.830-837
Hauptverfasser: Ahn, Jonghwa, Jin, Meihua, Song, Eyun, Jeon, Min Ji, Kim, Tae Yong, Ryu, Jin-Sook, Kim, Won Bae, Shong, Young Kee, Han, Ji Min, Kim, Won Gu
Format: Artikel
Sprache:eng
Schlagworte:
iodine radioisotopes
Original
papillary
prognosis
recurrence
thyroid cancer
thyroid neoplasms
내과학
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The clinical outcomes of delayed radioiodine remnant ablation (RRA) therapy in patients with low-risk papillary thyroid carcinoma (PTC) are unclear. We aimed to evaluate the clinical impact of the interval between total thyroidectomy (TT) and RRA therapy in patients with low-risk PTC. We included 526 patients who underwent TT and RRA for low-risk PTC with a primary tumor size of >1 cm between 2000 and 2012. Patients were divided into the early (3 months after TT considering other prognostic factors.
ISSN:2093-596X
2093-5978
DOI:10.3803/EnM.2020.747